Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
US9090566B2 · kind B2 · utility
1Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2012 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Dec 21, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound, that iswherein Y, W, Z, R1, R2, R4, R5 and R6 are as defined in the specification.The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.